30 Day Trial

AlloSource and Stryker Launch ProChondrix CR Allograft


AlloSource and Stryker launched ProChondrix® CR cryopreserved osteochondral allograft for articular cartilage repair.

ProChondrix cellular 3D fresh cartilage allograft was launched in 2016 to support cartilage regeneration. CR, the cryopreserved format, performs the same functions that mimic biomechanical and biochemical properties of hyaline cartilage, and also offers an extended shelf life.

Stryker distributes AlloSource biologic sports medicine products per terms of an agreement entered in 2017.

Sources: AlloSource; ORTHOWORLD Inc.